1Surgical Service, Veterans Affairs Medical Center, Washington, D.C., USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Cucurbitacin E (CuE) potently inhibits proliferating human endothelial cells by disrupting their actin cytoskeleton. This actin-disrupting agent shows preferential toxicity towards rapidly dividing cells, offering a potential therapeutic strategy for vascular proliferation.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: